Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 492,052
  • Shares Outstanding, K 46,640
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.38
  • Price/Sales 2.10
  • Price/Cash Flow 4.29
  • Price/Book 12.18

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.45 +11.64%
on 11/02/17
10.85 -2.76%
on 11/01/17
+0.20 (+1.93%)
since 10/17/17
3-Month
9.45 +11.64%
on 11/02/17
13.15 -19.77%
on 09/11/17
+0.50 (+4.98%)
since 08/17/17
52-Week
9.30 +13.44%
on 04/18/17
17.55 -39.89%
on 11/30/16
-4.83 (-31.40%)
since 11/17/16

Most Recent Stories

More News
Collegium (COLL) in Focus: Stock Moves 6.9% Higher

Collegium Pharmaceutical (COLL) was a big mover last session, as the company saw its shares rise nearly 7% on the day amid huge volumes.

COLL : 17.14 (+1.90%)
SCMP : 10.55 (+1.93%)
Incyte (INCY) Initiates Essential Thrombocythemia Trial

Incyte (INCY) announced that the first patient has been treated in the essential thrombocythemia trial on ruxolitinib. A potential label expansion of the drug will boost sales.

CORT : 18.39 (-3.46%)
SCMP : 10.55 (+1.93%)
INCY : 105.47 (-0.95%)
NVS : 83.98 (+1.16%)
Achillion (ACHN) Shares Down as J&J Announces Stake Sale

Achillion's (ACHN) shares fell following the announcement that J&J will sell its complete stake in the company.

SCMP : 10.55 (+1.93%)
ACHN : 3.43 (-3.65%)
JNJ : 138.00 (-0.63%)
ALXN : 110.87 (+0.49%)
Valeant (VRX) Announces Pricing of Senior Secured Notes

Valeant (VRX) prices its senior secured notes. The proceeds of the notes will be used to pay down its existing debt.

CORT : 18.39 (-3.46%)
LGND : 140.31 (-0.99%)
SCMP : 10.55 (+1.93%)
VRX : 14.69 (+2.44%)
Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test

Roche's (RHHBY) diagnostic portfolio gets a further boost with FDA's clearance for Ventana tests.

CORT : 18.39 (-3.46%)
SCMP : 10.55 (+1.93%)
NVS : 83.98 (+1.16%)
RHHBY : 29.1000 (+0.71%)
Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee

Pacira (PCRX) announced that the FDA has asked for an Advisory Committee Meeting to review the supplemental New Drug Application for expanded indication of Exparel in the nerve block setting.

CORT : 18.39 (-3.46%)
LGND : 140.31 (-0.99%)
SCMP : 10.55 (+1.93%)
PCRX : 40.25 (+1.90%)
Cardinal Health (CAH) to Divest Assets to Shanghai Pharma

Cardinal Health (CAH) will streamline its Chinese operations by disposing pharmaceutical and medical products distribution business in China.

CORT : 18.39 (-3.46%)
SCMP : 10.55 (+1.93%)
ACHN : 3.43 (-3.65%)
CAH : 57.51 (+0.16%)
Glaxo's Subcutaneous Formulation of Benlysta Approved in EU

GlaxoSmithKline's (GSK) Benlysta receives approval for a new subcutaneous formulation in Europe as an add-on therapy for patients with SLE.

CORT : 18.39 (-3.46%)
SCMP : 10.55 (+1.93%)
ACHN : 3.43 (-3.65%)
GSK : 35.06 (-0.37%)
Orexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up

Orexigen (OREX) reported a narrower-than-expected loss on higher Contrave volumes.

OREX : 1.69 (+4.32%)
SCMP : 10.55 (+1.93%)
TEVA : 13.84 (+8.21%)
MKGAF : 107.5000 (+1.19%)
Sucampo to Host 2017 R&D Day on November 16 in New York

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day for the investment community on Thursday, November 16, 2017...

SCMP : 10.55 (+1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Key Turning Points

2nd Resistance Point 10.75
1st Resistance Point 10.65
Last Price 10.55
1st Support Level 10.35
2nd Support Level 10.15

See More

52-Week High 17.55
Fibonacci 61.8% 14.40
Fibonacci 50% 13.42
Fibonacci 38.2% 12.45
Last Price 10.55
52-Week Low 9.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart